Featured Research

from universities, journals, and other organizations

Nanotech Decoys For Viruses

Date:
March 20, 2003
Source:
University Of California, Davis
Summary:
Using nanotechnology to stop HIV viruses from entering cells is the ultimate aim of a new project at the University of California, Davis. The researchers hope to create tiny particles that can interfere with the proteins that viruses such as HIV use to attach to cells.

Using nanotechnology to stop HIV viruses from entering cells is the ultimate aim of a new project at the University of California, Davis. The researchers hope to create tiny particles that can interfere with the proteins that viruses such as HIV use to attach to cells.

Related Articles


"The idea is to make decoys for the virus," said Jacquelyn Gervay Hague, professor of chemistry at UC Davis and principal investigator on the grant.

HIV attaches itself to a host cell through a protein called gp120 on the virus surface. Gp120 sticks to the CD4 protein on human white blood cells and also to a fatty molecule called galactosyl ceramide, or GalCer. GalCer is found in the membranes of many different types of cell, including cells lining the gut and vagina. Researchers think that binding of gp120 to GalCer may be important in sexual transmission of HIV.

GalCer can form patterns in the cell membrane that allow many gp120 proteins to bind in a specific manner, Gervay Hague said. Materials scientist Marjorie Longo and her lab are studying how GalCer forms these patterns in artificial membranes and how they affect binding to viruses.

If the researchers find a pattern that maximizes binding, they will use tools developed by chemist Gang-yu Liu to recreate those patterns on lipid-coated "quantum dots," tiny particles a few tens of atoms in size. The quantum dots are made by Susan Kauzlarich, a professor of chemistry who studies these very small particles. The particles will be tested for antiviral activity by Satya Dandekar, professor and chair of microbiology and immunology at the UC Davis School of Medicine.

The researchers' ultimate goal is to create a quantum dot that can stick to the virus and prevent it from entering human cells.

The group has already made gold nanoparticles coated with a non-patterned membrane. These particles are not toxic to cells and were able to bind gp120, Gervay Hague said.

The work is funded by a $1.2 million Nanoscale Interdisciplinary Research Team grant from the National Science Foundation.


Story Source:

The above story is based on materials provided by University Of California, Davis. Note: Materials may be edited for content and length.


Cite This Page:

University Of California, Davis. "Nanotech Decoys For Viruses." ScienceDaily. ScienceDaily, 20 March 2003. <www.sciencedaily.com/releases/2003/03/030320074955.htm>.
University Of California, Davis. (2003, March 20). Nanotech Decoys For Viruses. ScienceDaily. Retrieved November 28, 2014 from www.sciencedaily.com/releases/2003/03/030320074955.htm
University Of California, Davis. "Nanotech Decoys For Viruses." ScienceDaily. www.sciencedaily.com/releases/2003/03/030320074955.htm (accessed November 28, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Friday, November 28, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Ebola Leaves Orphans Alone in Sierra Leone

Ebola Leaves Orphans Alone in Sierra Leone

AFP (Nov. 27, 2014) — The Ebola epidemic sweeping Sierra Leone is having a profound effect on the country's children, many of whom have been left without any family members to support them. Duration: 01:02 Video provided by AFP
Powered by NewsLook.com
Experimental Ebola Vaccine Shows Promise In Human Trial

Experimental Ebola Vaccine Shows Promise In Human Trial

Newsy (Nov. 27, 2014) — A recent test of a prototype Ebola vaccine generated an immune response to the disease in subjects. Video provided by Newsy
Powered by NewsLook.com
Pet Dogs to Be Used in Anti-Ageing Trial

Pet Dogs to Be Used in Anti-Ageing Trial

Reuters - Innovations Video Online (Nov. 26, 2014) — Researchers in the United States are preparing to discover whether a drug commonly used in human organ transplants can extend the lifespan and health quality of pet dogs. Video provided by Reuters
Powered by NewsLook.com
Today's Prostheses Are More Capable Than Ever

Today's Prostheses Are More Capable Than Ever

Newsy (Nov. 26, 2014) — Advances in prosthetics are making replacement body parts stronger and more lifelike than they’ve ever been. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins